Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology
Kelly Del Tredici, Heiko Braak
Neuropathology and Applied Neurobiology (2015) Vol. 42, Iss. 1, pp. 33-50
Closed Access | Times Cited: 342

Showing 26-50 of 342 citing articles:

A Cortical Pathogenic Theory of Parkinson’s Disease
Guglielmo Foffani, José Á. Obeso
Neuron (2018) Vol. 99, Iss. 6, pp. 1116-1128
Open Access | Times Cited: 137
Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
Chin‐Hsien Lin, Shieh‐Yueh Yang, H. E. Horng, et al.
Journal of Neurology Neurosurgery & Psychiatry (2017) Vol. 88, Iss. 10, pp. 818-824
Open Access | Times Cited: 132
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Javier Campos‐Acuña, Daniela Elgueta, Rodrigo Pacheco
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 116
Chronic pain and pain processing in Parkinson's disease
Pierre J. Blanchet, Christine Brefel‐Courbon
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2017) Vol. 87, pp. 200-206
Open Access | Times Cited: 112
Diet in Parkinson's Disease: Critical Role for the Microbiome
Aeja Jackson, Christopher B. Forsyth, Maliha Shaikh, et al.
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 107
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
Regina H. Reynolds, Juan A. Botía, Mike A. Nalls, et al.
npj Parkinson s Disease (2019) Vol. 5, Iss. 1
Open Access | Times Cited: 106
Potential Roles of Exosomes in Parkinson’s Disease: From Pathogenesis, Diagnosis, and Treatment to Prognosis
Haiyang Yu, Tong Sun, Jing An, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 105
The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
José Fidel Baizabal‐Carvallo, Marlene Alonso-Juárez
Neuroscience (2020) Vol. 432, pp. 160-173
Closed Access | Times Cited: 98
Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology
Lilian Calderón‐Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, et al.
Environmental Research (2018) Vol. 166, pp. 348-362
Closed Access | Times Cited: 96
The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction
G. Bellomo, Silvia Paciotti, Leonardo Gatticchi, et al.
Movement Disorders (2019) Vol. 35, Iss. 1, pp. 34-44
Closed Access | Times Cited: 93
Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
Inês Caldeira Brás, Tiago F. Outeiro
Cells (2021) Vol. 10, Iss. 2, pp. 375-375
Open Access | Times Cited: 92
α-Synuclein conformational strains spread, seed and target neuronal cells differentially after injection into the olfactory bulb
Nolwen L. Rey, Luc Bousset, Sonia George, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 89
Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
Lijuan Hou, Wei Chen, Xiaoli Liu, et al.
Frontiers in Aging Neuroscience (2017) Vol. 9
Open Access | Times Cited: 88
Chronic Mild Gut Inflammation Accelerates Brain Neuropathology and Motor Dysfunction in α-Synuclein Mutant Mice
Yuki Kishimoto, Wandi S. Zhu, Waki Hosoda, et al.
NeuroMolecular Medicine (2019) Vol. 21, Iss. 3, pp. 239-249
Open Access | Times Cited: 85
Using Rotenone to Model Parkinson’s Disease in Mice: A Review of the Role of Pharmacokinetics
Jürgen Innos, Miriam A. Hickey
Chemical Research in Toxicology (2021) Vol. 34, Iss. 5, pp. 1223-1239
Closed Access | Times Cited: 85
α-Synuclein fibrils subvert lysosome structure and function for the propagation of protein misfolding between cells through tunneling nanotubes
Aysegul Dilsizoglu Senol, Maura Samarani, Sylvie Syan, et al.
PLoS Biology (2021) Vol. 19, Iss. 7, pp. e3001287-e3001287
Open Access | Times Cited: 81
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
Asad Jan, Nádia Pereira Gonçalves, Christian B. Vægter, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8338-8338
Open Access | Times Cited: 77
The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson’s disease
Jessica Vargas, Clara Grudina, Chiara Zurzolo
Ageing Research Reviews (2019) Vol. 50, pp. 89-101
Open Access | Times Cited: 76
Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease
Aline Delva, Donatienne Van Weehaeghe, Michel Koole, et al.
Movement Disorders (2020) Vol. 35, Iss. 11, pp. 1977-1986
Open Access | Times Cited: 74
Quadruple abnormal protein aggregates in brainstem pathology and exogenous metal-rich magnetic nanoparticles (and engineered Ti-rich nanorods). The substantia nigrae is a very early target in young urbanites and the gastrointestinal tract a key brainstem portal
Lilian Calderón‐Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, et al.
Environmental Research (2020) Vol. 191, pp. 110139-110139
Open Access | Times Cited: 74
Global and Regional Changes in Perivascular Space in Idiopathic and Familial Parkinson's Disease
Erin K. Donahue, Amjad Murdos, Michael W. Jakowec, et al.
Movement Disorders (2021) Vol. 36, Iss. 5, pp. 1126-1136
Open Access | Times Cited: 73
Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
Nolwazi Z. Gcwensa, Drèson L. Russell, Rita M. Cowell, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 70
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 62
Alterations of gut microbiota and metabolome with Parkinson's disease
Zhenzhen Yan, Fan Yang, Jingwei Cao, et al.
Microbial Pathogenesis (2021) Vol. 160, pp. 105187-105187
Closed Access | Times Cited: 62
Are We What We Eat? Impact of Diet on the Gut–Brain Axis in Parkinson’s Disease
Margherita Alfonsetti, Vanessa Castelli, Michele d’Angelo
Nutrients (2022) Vol. 14, Iss. 2, pp. 380-380
Open Access | Times Cited: 43

Scroll to top